Health Care & Life Sciences » Pharmaceuticals | Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$0.06
Market Cap
$718.15 K
Shares Outstanding
196.75 M
Public Float
182.8 M

Profile

Address
38 West Main Street
Hancock Maryland 21750
United States
Employees -
Website http://www.petlifepharma.com
Updated 07/08/2019
Petlife Pharmaceuticals, Inc. engages in the research, development, sales, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases. Its products include preventative, tabs, and pet foods under the brand name Vitalzul. The company was founded on June 26, 2014 and is headquartered in Hancock, MD.

Financials

View All

Sebastian Serrell-Watts
Chairman, President, CEO, CFO & Secretary
Sebastian Serrell-Watts
Chairman, President, CEO, CFO & Secretary